๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

PERGOLIDE AND LISURIDE FOR PARKINSON'S DISEASE

โœ Scribed by Lieberman, AbrahamN.; Leibowitz, Morton; Neophytides, Andreas; Kupersmith, Mark; Mehl, Sidney; Kleinberg, David; Serby, Michael; Goldstein, Menek


Book ID
122915198
Publisher
The Lancet
Year
1979
Tongue
English
Weight
318 KB
Volume
314
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


LISURIDE IN PARKINSON'S DISEASE
โœ Dick, J.P.R.; George, R.J.D.; Marsden, C.D.; Parkes, J.D.; Schachter, M.; Blacks ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› The Lancet ๐ŸŒ English โš– 155 KB
Intravenous lisuride infusion for Parkin
โœ J. A. Obeso; J. M. Martinez-Lage; M. R. Luquin; N. Bolio ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 127 KB ๐Ÿ‘ 2 views
LISURIDE INFUSION PUMP FOR PARKINSON'S D
โœ Ruggieri, Stefano; Stocchi, Fabrizio; Agnoli, Alessandro; Bittkau, S.; Przuntek, ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› The Lancet ๐ŸŒ English โš– 314 KB
Pergolide therapy in parkinson's disease
โœ P. Jeanty; M. Kerchove; A. Lowenthal; H. Bruyne ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 543 KB

A total of 26 patients were treated with pergolide mesylate, a semi-synthetic ergot derivative with the property of direct dopamine activity. Of these patients, 18 suffered from late failure of L-dopa, while the remaining 8 had never before been treated with L-dopa. The aim of the trial was to study